14-day Premium Trial Subscription Sign Up For FreeGet Free

ARRY Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 30.09% during the next 3 months and, with a 90% probability hold a price between $20.17 and $26.53 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $15.58 $18.02 $20.47
2021-09-23 $15.66 $18.10 $20.54
2021-09-24 $15.73 $18.17 $20.62
2021-09-27 $15.81 $18.25 $20.69
2021-09-28 $15.88 $18.32 $20.77
2021-09-29 $15.95 $18.40 $20.84
2021-09-30 $16.03 $18.47 $20.92
2021-10-01 $16.10 $18.55 $20.99
2021-10-04 $16.18 $18.62 $21.07
2021-10-05 $16.25 $18.70 $21.14
2021-10-06 $16.33 $18.77 $21.22
2021-10-07 $16.40 $18.85 $21.29
2021-10-08 $16.48 $18.92 $21.37
2021-10-11 $16.55 $19.00 $21.44
2021-10-12 $16.63 $19.07 $21.52
2021-10-13 $16.70 $19.15 $21.59
2021-10-14 $16.78 $19.22 $21.67
2021-10-15 $16.85 $19.30 $21.74
2021-10-18 $16.93 $19.37 $21.82
2021-10-19 $17.00 $19.45 $21.89
2021-10-20 $17.08 $19.52 $21.97
2021-10-21 $17.15 $19.60 $22.04
2021-10-22 $17.23 $19.67 $22.12
2021-10-25 $17.30 $19.75 $22.19
2021-10-26 $17.38 $19.82 $22.27
2021-10-27 $17.45 $19.90 $22.34
2021-10-28 $17.53 $19.97 $22.42
2021-10-29 $17.60 $20.05 $22.49
2021-11-01 $17.68 $20.12 $22.57
2021-11-02 $17.75 $20.20 $22.64

About Array Technologies, Inc.

Array Technologies Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company’s drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II cl... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT